Literature DB >> 15551049

[The infected implant. Part 1: bacteriology].

U Geipel1, M Herrmann.   

Abstract

Periprosthetic infection is a significant complication in joint replacement surgery and develops in 0.5-2% of cases. Staphylococcus aureus and commensal microorganisms of the skin, especially coagulase-negative staphylococci, as well as a broad spectrum of other potential pathogens typically already colonize the surface of the foreign body at the time of implantation. Specific mechanisms such as bacterial adhesion to host factors absorbed in the material, biofilm formation, and a metabolic adaptation of adherent microorganisms play a particularly important role in the pathogenesis and course of the disease. Microbiological diagnosis requires to some extent complex culture procedures of puncture specimens or tissue removed during surgery; this can be supplemented by modern molecular testing. Antimicrobial treatment must be conceived as a synopsis of clinical picture, confirmed pathogen, and the intended surgical procedure on an individual basis and is routinely administered as combination therapy for several weeks, sometimes also as sequential therapy. Validated preventive measures in joint replacement surgery include mandatory perioperative antibiotic prophylaxis and other additional measures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15551049     DOI: 10.1007/s00132-004-0741-1

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  23 in total

Review 1.  Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review.

Authors:  H van de Belt; D Neut; W Schenk; J R van Horn; H C van der Mei; H J Busscher
Journal:  Acta Orthop Scand       Date:  2001-12

2.  Genetic and biochemical analysis of Staphylococcus epidermidis biofilm accumulation.

Authors:  D Mack; K Bartscht; C Fischer; H Rohde; C de Grahl; S Dobinsky; M A Horstkotte; K Kiel; J K Knobloch
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

3.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.

Authors:  D C Classen; R S Evans; S L Pestotnik; S D Horn; R L Menlove; J P Burke
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

4.  Prophylactic use of antibiotics for procedures after total joint replacement.

Authors:  J M Deacon; A J Pagliaro; S B Zelicof; H W Horowitz
Journal:  J Bone Joint Surg Am       Date:  1996-11       Impact factor: 5.284

5.  Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group.

Authors:  B L Atkins; N Athanasou; J J Deeks; D W Crook; H Simpson; T E Peto; P McLardy-Smith; A R Berendt
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 6.  Antimicrobial treatment of chronic osteomyelitis.

Authors:  J T Mader; M E Shirtliff; S C Bergquist; J Calhoun
Journal:  Clin Orthop Relat Res       Date:  1999-03       Impact factor: 4.176

7.  Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.

Authors:  R N Greenberg; M T Newman; S Shariaty; R W Pectol
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

8.  Risk factors for prosthetic joint infection: case-control study.

Authors:  E F Berbari; A D Hanssen; M C Duffy; J M Steckelberg; D M Ilstrup; W S Harmsen; D R Osmon
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

9.  Small colony variants in staphylococcal infections: diagnostic and therapeutic implications.

Authors:  R A Proctor; G Peters
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

Review 10.  Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America.

Authors:  E P Dellinger; P A Gross; T L Barrett; P J Krause; W J Martone; J E McGowan; R L Sweet; R P Wenzel
Journal:  Clin Infect Dis       Date:  1994-03       Impact factor: 9.079

View more
  24 in total

1.  [Limits of clinical pathways. Implant-associated infections].

Authors:  J Seifert; S Apostel; M Frank; D Stengel; A Ekkernkamp
Journal:  Orthopade       Date:  2010-08       Impact factor: 1.087

2.  [Hip joint infections - Results of a questionnaire among 28 university orthopedic departments].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

3.  An extended spectrum bactericidal titanium dioxide (TiO2) coating for metallic implants: in vitro effectiveness against MRSA and mechanical properties.

Authors:  Maximilian Haenle; Andreas Fritsche; Carmen Zietz; Rainer Bader; Frank Heidenau; Wolfram Mittelmeier; Hans Gollwitzer
Journal:  J Mater Sci Mater Med       Date:  2010-12-29       Impact factor: 3.896

Review 4.  [Methicillin-resistant Staphylococcus aureus. Types of resistance and clinical consequences].

Authors:  U Geipel; M Herrmann
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

Review 5.  [Diagnostic strategies in cases of suspected periprosthetic infection of the knee. A review of the literature and current recommendations].

Authors:  H Gollwitzer; P Diehl; L Gerdesmeyer; W Mittelmeier
Journal:  Orthopade       Date:  2006-09       Impact factor: 1.087

6.  [The infected implant].

Authors:  J Wodtke; J F Löhr
Journal:  Orthopade       Date:  2008-03       Impact factor: 1.087

7.  [Periprosthetic infections following total hip replacement with ESBL-forming bacteria: importance for clinical practice].

Authors:  M Haenle; A Podbielski; M Ellenrieder; R Skripitz; K Arndt; W Mittelmeier; R Bader; H Gollwitzer
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

Review 8.  Molecular engineering of an orthopaedic implant: from bench to bedside.

Authors:  I M Shapiro; N J Hickok; J Parvizi; S Stewart; T P Schaer
Journal:  Eur Cell Mater       Date:  2012-05-24       Impact factor: 3.942

9.  Osseointegrated titanium implants for limb prostheses attachments: infectious complications.

Authors:  Jonatan Tillander; Kerstin Hagberg; Lars Hagberg; Rickard Brånemark
Journal:  Clin Orthop Relat Res       Date:  2010-05-15       Impact factor: 4.176

Review 10.  Pathogenic organisms in hip joint infections.

Authors:  Udo Geipel
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.